Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Facioscapulohumeral muscular dystrophy.

Silvère M van der Maarel1, Rune R Frants, George W Padberg

  • 1Leiden University Medical Center (LUMC), Department of Human Genetics, Postal zone S-3-P, PO box 9600, 2300 RC Leiden, The Netherlands. maarel@lumc.nl

Biochimica Et Biophysica Acta
|July 14, 2006
PubMed
Summary

Facioscapulohumeral muscular dystrophy (FSHD) stems from epigenetic changes at chromosome 4q. Current therapies are ineffective, highlighting the need for better disease models to develop novel interventions for FSHD patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MuSK antibodies differently affect the MuSK signaling cascade depending on valency and epitope specificity.

Journal of autoimmunity·2026
Same author

<i>Kbtbd13</i> knockdown restores muscle function in a clinically relevant mouse model of nemaline myopathy type 6.

Science translational medicine·2026
Same author

A portrait of facioscapulohumeral muscular dystrophy through history: past milestones and future challenges on the road to understanding and treatment.

Neuromuscular disorders : NMD·2026
Same author

The emergence and diversification of the DUX gene family across placental mammals.

Communications biology·2026
Same author

Fibro-adipogenic progenitors enhance functional and structural properties of human 3D tissue engineered skeletal muscles.

Journal of tissue engineering·2026
Same author

KLF18 is a necessary component of the DUX4-initiated transcriptional network and a candidate locus for phenotypic diversity.

Genes & development·2026

Area of Science:

  • Genetics
  • Epigenetics
  • Molecular Biology

Background:

  • Facioscapulohumeral muscular dystrophy (FSHD) is linked to D4Z4 repeat contraction on chromosome 4q.
  • The exact pathogenic mechanism, whether local or genome-wide, remains unclear.
  • Existing therapies for FSHD have yielded disappointing results.

Purpose of the Study:

  • To investigate the primary pathogenic process in FSHD muscle.
  • To evaluate the effectiveness of current therapeutic strategies.
  • To emphasize the need for improved FSHD disease models.

Main Methods:

  • Review of current understanding of FSHD pathogenesis.
  • Analysis of outcomes from clinical trials targeting inflammation and muscle mass.
  • Assessment of a pilot trial for epigenetic modification.

Related Experiment Videos

Main Results:

  • Evidence supports both local (chromosome 4q) and global epigenetic effects in FSHD.
  • Clinical trials targeting inflammation or muscle growth have been unsuccessful.
  • An initial epigenetic intervention trial did not warrant further study.

Conclusions:

  • A deeper understanding of FSHD's primary cause is crucial for effective treatment.
  • Current therapeutic approaches have failed to improve patient outcomes.
  • Development of superior FSHD disease models is essential for identifying and testing new interventions.